Loading clinical trials...

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain | Clinical Trials | Clareo Health

COMPLETEDPhase 3NCT05445167

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

Multi-center, randomized, double-blind, parallel-group study to confirm superiority of KLH-2109 to placebo in uterine fibroids patient with menorrhagia and pain

Lead sponsor: Kissei Pharmaceutical Co., Ltd.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment89

Start dateOct 2022

Last updatedNov 25, 2025

Condition

Uterine Fibroids (MeSH Heading: Leiomyoma)

Locations shown

Clinical Research Site

Multiple Locations

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 25, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions